Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Cancer Treatment Drugs Market 2017 Forecast to 2022

February 2017 | 120 pages | ID: GE0F495572EEN
GlobalInfoResearch

Abstracts

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

SCOPE OF THE REPORT:

This report focuses on the Cancer Treatment Drugs in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Roche
• Novartis
• Celgene
• Amgen
• Johnson & Johnson
• Bristol-Myers Squibb
• Takeda
• Eli Lilly
• Pfizer
• AstraZeneca
• Astellas
• Sanofi
• Bayer
• Merck & Co.
• Biogen Idec
• Kyowa Hakko Kirin
• Otsuka
• Teva
• Eisai
• Merck KGaA
• Ipsen
• AbbVie
• Gilead Sciences

Market Segment by Regions, regional analysis covers

• North America (USA, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Columbia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Others

Market Segment by Applications, can be divided into

• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Respiratory/Lung Cancer
• Other Cancers

There are 15 Chapters to deeply display the global Cancer Treatment Drugs market.

Chapter 1, to describe Cancer Treatment Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cancer Treatment Drugs, with sales, revenue, and price of Cancer Treatment Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Treatment Drugs, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Cancer Treatment Drugs market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Cancer Treatment Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Cancer Treatment Drugs Introduction
1.2 Market Analysis by Type
  1.2.1 Chemotherapy
  1.2.2 Targeted Therapy
  1.2.3 Immunotherapy (Biologic Therapy)
  1.2.4 Hormonal Therapy
  1.2.5 Others
1.3 Market Analysis by Applications
  1.3.1 Blood Cancer
  1.3.2 Breast Cancer
  1.3.3 Gastrointestinal Cancer
  1.3.4 Prostate Cancer
  1.3.5 Respiratory/Lung Cancer
  1.3.6 Other Cancers
1.4 Market Analysis by Regions
  1.4.1 North America (USA, Canada and Mexico)
    1.4.1.1 USA Market States and Outlook (2012-2022)
    1.4.1.2 Canada Market States and Outlook (2012-2022)
    1.4.1.3 Mexico Market States and Outlook (2012-2022)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2012-2022)
    1.4.2.2 France Market States and Outlook (2012-2022)
    1.4.2.3 UK Market States and Outlook (2012-2022)
    1.4.2.4 Russia Market States and Outlook (2012-2022)
    1.4.2.5 Italy Market States and Outlook (2012-2022)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2012-2022)
    1.4.3.2 Japan Market States and Outlook (2012-2022)
    1.4.3.3 Korea Market States and Outlook (2012-2022)
    1.4.3.4 India Market States and Outlook (2012-2022)
    1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2012-2022)
    1.4.4.2 Egypt Market States and Outlook (2012-2022)
    1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.4.4 South Africa Market States and Outlook (2012-2022)
    1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Roche
  2.1.1 Business Overview
  2.1.2 Cancer Treatment Drugs Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
  2.2.1 Business Overview
  2.2.2 Cancer Treatment Drugs Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Celgene
  2.3.1 Business Overview
  2.3.2 Cancer Treatment Drugs Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Amgen
  2.4.1 Business Overview
  2.4.2 Cancer Treatment Drugs Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
  2.5.1 Business Overview
  2.5.2 Cancer Treatment Drugs Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bristol-Myers Squibb
  2.6.1 Business Overview
  2.6.2 Cancer Treatment Drugs Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Takeda
  2.7.1 Business Overview
  2.7.2 Cancer Treatment Drugs Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Eli Lilly
  2.8.1 Business Overview
  2.8.2 Cancer Treatment Drugs Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
  2.9.1 Business Overview
  2.9.2 Cancer Treatment Drugs Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca
  2.10.1 Business Overview
  2.10.2 Cancer Treatment Drugs Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Astellas
  2.11.1 Business Overview
  2.11.2 Cancer Treatment Drugs Type and Applications
    2.11.2.1 Type
    2.11.2.2 Type
  2.11.3 Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Sanofi
  2.12.1 Business Overview
  2.12.2 Cancer Treatment Drugs Type and Applications
    2.12.2.1 Type
    2.12.2.2 Type
  2.12.3 Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Bayer
  2.13.1 Business Overview
  2.13.2 Cancer Treatment Drugs Type and Applications
    2.13.2.1 Type
    2.13.2.2 Type
  2.13.3 Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Merck & Co.
  2.14.1 Business Overview
  2.14.2 Cancer Treatment Drugs Type and Applications
    2.14.2.1 Type
    2.14.2.2 Type
  2.14.3 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Biogen Idec
  2.15.1 Business Overview
  2.15.2 Cancer Treatment Drugs Type and Applications
    2.15.2.1 Type
    2.15.2.2 Type
  2.15.3 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Kyowa Hakko Kirin
  2.16.1 Business Overview
  2.16.2 Cancer Treatment Drugs Type and Applications
    2.16.2.1 Type
    2.16.2.2 Type
  2.16.3 Kyowa Hakko Kirin Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Otsuka
  2.17.1 Business Overview
  2.17.2 Cancer Treatment Drugs Type and Applications
    2.17.2.1 Type
    2.17.2.2 Type
  2.17.3 Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Teva
  2.18.1 Business Overview
  2.18.2 Cancer Treatment Drugs Type and Applications
    2.18.2.1 Type
    2.18.2.2 Type
  2.18.3 Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Eisai
  2.19.1 Business Overview
  2.19.2 Cancer Treatment Drugs Type and Applications
    2.19.2.1 Type
    2.19.2.2 Type
  2.19.3 Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Merck KGaA
  2.20.1 Business Overview
  2.20.2 Cancer Treatment Drugs Type and Applications
    2.20.2.1 Type
    2.20.2.2 Type
  2.20.3 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Ipsen
  2.21.1 Business Overview
  2.2.2 Cancer Treatment Drugs Type and Applications
    2.21.2.1 Type
    2.21.2.2 Type
  2.21.3 Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 AbbVie
  2.22.1 Business Overview
  2.22.2 Cancer Treatment Drugs Type and Applications
    2.22.2.1 Type
    2.22.2.2 Type
  2.22.3 AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.23 Gilead Sciences
  2.23.1 Business Overview
  2.23.2 Cancer Treatment Drugs Type and Applications
    2.23.2.1 Type
    2.23.2.2 Type
  2.23.3 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL CANCER TREATMENT DRUGS MARKET COMPETITION, BY MANUFACTURER

3.1 Global Cancer Treatment Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cancer Treatment Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Cancer Treatment Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Cancer Treatment Drugs Manufacturer Market Share
  3.4.2 Top 5 Cancer Treatment Drugs Manufacturer Market Share
3.5 Market Competition Trend

4 GLOBAL CANCER TREATMENT DRUGS MARKET ANALYSIS BY REGIONS

4.1 Global Cancer Treatment Drugs Sales, Revenue and Market Share by Regions
  4.1.1 Global Cancer Treatment Drugs Sales by Regions (2012-2017)
  4.1.2 Global Cancer Treatment Drugs Revenue by Regions (2012-2017)
4.2 North America Cancer Treatment Drugs Sales and Growth (2012-2017)
4.3 Europe Cancer Treatment Drugs Sales and Growth (2012-2017)
4.4 Asia-Pacific Cancer Treatment Drugs Sales and Growth (2012-2017)
4.5 South America Cancer Treatment Drugs Sales and Growth (2012-2017)
4.6 Middle East and Africa Cancer Treatment Drugs Sales and Growth (2012-2017)

5 NORTH AMERICA CANCER TREATMENT DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
  5.1.1 North America Cancer Treatment Drugs Sales by Countries (2012-2017)
  5.1.2 North America Cancer Treatment Drugs Revenue by Countries (2012-2017)
  5.1.3 USA Cancer Treatment Drugs Sales and Growth (2012-2017)
  5.1.4 Canada Cancer Treatment Drugs Sales and Growth (2012-2017)
  5.1.5 Mexico Cancer Treatment Drugs Sales and Growth (2012-2017)
5.2 North America Cancer Treatment Drugs Sales and Revenue (value) by Manufacturers (2016-2017)
  5.2.1 North America Cancer Treatment Drugs Sales by Manufacturers (2016-2017)
  5.2.2 North America Cancer Treatment Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Cancer Treatment Drugs Sales by Type (2012-2017)
5.4 North America Cancer Treatment Drugs Sales by Application (2012-2017)

6 EUROPE CANCER TREATMENT DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
  6.1.1 Europe Cancer Treatment Drugs Sales by Countries (2012-2017)
  6.1.2 Europe Cancer Treatment Drugs Revenue by Countries (2012-2017)
  6.1.3 Germany Cancer Treatment Drugs Sales and Growth (2012-2017)
  6.1.4 UK Cancer Treatment Drugs Sales and Growth (2012-2017)
  6.1.5 France Cancer Treatment Drugs Sales and Growth (2012-2017)
  6.1.6 Russia Cancer Treatment Drugs Sales and Growth (2012-2017)
  6.1.7 Italy Cancer Treatment Drugs Sales and Growth (2012-2017)
6.2 Europe Cancer Treatment Drugs Sales and Revenue (value) by Manufacturers (2016-2017)
  6.2.1 Europe Cancer Treatment Drugs Sales by Manufacturers (2016-2017)
  6.2.2 Europe Cancer Treatment Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Cancer Treatment Drugs Sales by Type (2012-2017)
6.4 Europe Cancer Treatment Drugs Sales by Application (2012-2017)

7 ASIA-PACIFIC CANCER TREATMENT DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Cancer Treatment Drugs Sales by Countries (2012-2017)
  7.1.2 Asia-Pacific Cancer Treatment Drugs Revenue by Countries (2012-2017)
  7.1.3 China Cancer Treatment Drugs Sales and Growth (2012-2017)
  7.1.4 Japan Cancer Treatment Drugs Sales and Growth (2012-2017)
  7.1.5 Korea Cancer Treatment Drugs Sales and Growth (2012-2017)
  7.1.6 India Cancer Treatment Drugs Sales and Growth (2012-2017)
  7.1.7 Southeast Asia Cancer Treatment Drugs Sales and Growth (2012-2017)
7.2 Asia-Pacific Cancer Treatment Drugs Sales and Revenue (value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Cancer Treatment Drugs Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Cancer Treatment Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Cancer Treatment Drugs Sales by Type (2012-2017)
7.4 Asia-Pacific Cancer Treatment Drugs Sales by Application (2012-2017)

8 SOUTH AMERICA CANCER TREATMENT DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
  8.1.1 South America Cancer Treatment Drugs Sales by Countries (2012-2017)
  8.1.2 South America Cancer Treatment Drugs Revenue by Countries (2012-2017)
  8.1.3 Brazil Cancer Treatment Drugs Sales and Growth (2012-2017)
  8.1.4 Argentina Cancer Treatment Drugs Sales and Growth (2012-2017)
  8.1.5 Columbia Cancer Treatment Drugs Sales and Growth (2012-2017)
8.2 South America Cancer Treatment Drugs Sales and Revenue (value) by Manufacturers (2016-2017)
  8.2.1 South America Cancer Treatment Drugs Sales by Manufacturers (2016-2017)
  8.2.2 South America Cancer Treatment Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Cancer Treatment Drugs Sales by Type (2012-2017)
8.4 South America Cancer Treatment Drugs Sales by Application (2012-2017)

9 MIDDLE EAST AND AFRICA CANCER TREATMENT DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Cancer Treatment Drugs Sales by Countries (2012-2017)
  9.1.2 Middle East and Africa Cancer Treatment Drugs Revenue by Countries (2012-2017)
  9.1.3 Saudi Arabia Cancer Treatment Drugs Sales and Growth (2012-2017)
  9.1.4 UAE Cancer Treatment Drugs Sales and Growth (2012-2017)
  9.1.5 Egypt Cancer Treatment Drugs Sales and Growth (2012-2017)
  9.1.6 Nigeria Cancer Treatment Drugs Sales and Growth (2012-2017)
  9.1.7 South Africa Cancer Treatment Drugs Sales and Growth (2012-2017)
9.2 Middle East and Africa Cancer Treatment Drugs Sales and Revenue (value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Cancer Treatment Drugs Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Cancer Treatment Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Cancer Treatment Drugs Sales by Type (2012-2017)
9.4 Middle East and Africa Cancer Treatment Drugs Sales by Application (2012-2017)

10 GLOBAL CANCER TREATMENT DRUGS MARKET SEGMENT BY TYPE

10.1 Global Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2012-2017)
  10.1.1 Global Cancer Treatment Drugs Sales and Market Share by Type (2012-2017)
  10.1.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017)
10.2 Chemotherapy Sales Growth and Price
  10.2.1 Global Chemotherapy Sales Growth (2012-2017)
  10.2.2 Global Chemotherapy Price (2012-2017)
10.3 Targeted Therapy Sales Growth and Price
  10.3.1 Global Targeted Therapy Sales Growth (2012-2017)
  10.3.2 Global Targeted Therapy Price (2012-2017)
10.4 Immunotherapy (Biologic Therapy) Sales Growth and Price
  10.4.1 Global Immunotherapy (Biologic Therapy) Sales Growth (2012-2017)
  10.4.2 Global Immunotherapy (Biologic Therapy) Price (2012-2017)
10.5 Hormonal Therapy Sales Growth and Price
  10.5.1 Global Hormonal Therapy Sales Growth (2012-2017)
  10.5.2 Global Hormonal Therapy Price (2012-2017)
10.6 Others Sales Growth and Price
  10.6.1 Global Others Sales Growth (2012-2017)
  10.6.2 Global Others Price (2012-2017)

11 GLOBAL CANCER TREATMENT DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
11.2 Blood Cancer Sales Growth (2012-2017)
11.3 Breast Cancer Sales Growth (2012-2017)
11.4 Gastrointestinal Cancer Sales Growth (2012-2017)
11.5 Prostate Cancer Sales Growth (2012-2017)
11.6 Respiratory/Lung Cancer Sales Growth (2012-2017)
11.7 Other Cancers Sales Growth (2012-2017)

12 CANCER TREATMENT DRUGS MARKET FORECAST (2017-2022)

12.1 Global Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022)
12.2 Cancer Treatment Drugs Market Forecast by Regions (2017-2022)
  12.2.1 North America Cancer Treatment Drugs Market Forecast (2017-2022)
  12.2.2 Europe Cancer Treatment Drugs Market Forecast (2017-2022)
  12.2.3 Asia-Pacific Cancer Treatment Drugs Market Forecast (2017-2022)
  12.2.4 South America Cancer Treatment Drugs Market Forecast (2017-2022)
  12.2.5 Middle East and Africa Cancer Treatment Drugs Market Forecast (2017-2022)
12.3 Cancer Treatment Drugs Market Forecast by Type (2017-2022)
12.4 Cancer Treatment Drugs Market Forecast by Application (2017-2022)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Cancer Treatment Drugs Picture
Table Product Specifications of Cancer Treatment Drugs
Figure Global Sales Market Share of Cancer Treatment Drugs by Types in 2016
Table Cancer Treatment Drugs Types for Major Manufacturers
Figure Chemotherapy Picture
Figure Targeted Therapy Picture
Figure Immunotherapy (Biologic Therapy) Picture
Figure Hormonal Therapy Picture
Figure Others Picture
Table Cancer Treatment Drugs Sales Market Share by Applications in 2016
Figure Blood Cancer Picture
Figure Breast Cancer Picture
Figure Gastrointestinal Cancer Picture
Figure Prostate Cancer Picture
Figure Respiratory/Lung Cancer Picture
Figure Other Cancers Picture
Figure USA Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure France Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure UK Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure China Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Japan Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Korea Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure India Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Southeast Asia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Brazil Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Cancer Treatment Drugs Revenue (Value) and Growth Rate (2012-2022)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cancer Treatment Drugs Type and Applications
Table Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Cancer Treatment Drugs Type and Applications
Table Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Cancer Treatment Drugs Type and Applications
Table Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Cancer Treatment Drugs Type and Applications
Table Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Cancer Treatment Drugs Type and Applications
Table Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Cancer Treatment Drugs Type and Applications
Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Cancer Treatment Drugs Type and Applications
Table Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Cancer Treatment Drugs Type and Applications
Table Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Cancer Treatment Drugs Type and Applications
Table Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Cancer Treatment Drugs Type and Applications
Table AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Basic Information, Manufacturing Base and Competitors
Table Astellas Cancer Treatment Drugs Type and Applications
Table Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Cancer Treatment Drugs Type and Applications
Table Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Cancer Treatment Drugs Type and Applications
Table Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Cancer Treatment Drugs Type and Applications
Table Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Cancer Treatment Drugs Type and Applications
Table Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table Kyowa Hakko Kirin Cancer Treatment Drugs Type and Applications
Table Kyowa Hakko Kirin Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Basic Information, Manufacturing Base and Competitors
Table Otsuka Cancer Treatment Drugs Type and Applications
Table Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Cancer Treatment Drugs Type and Applications
Table Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Cancer Treatment Drugs Type and Applications
Table Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck KGaA Basic Information, Manufacturing Base and Competitors
Table Merck KGaA Cancer Treatment Drugs Type and Applications
Table Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen Basic Information, Manufacturing Base and Competitors
Table Ipsen Cancer Treatment Drugs Type and Applications
Table Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Cancer Treatment Drugs Type and Applications
Table AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Cancer Treatment Drugs Type and Applications
Table Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Global Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Global Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Global Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Global Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table Global Cancer Treatment Drugs Price by Manufacturer (2016-2017)
Figure Global Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Global Cancer Treatment Drugs Revenue and Growth (2012-2017)
Table Global Cancer Treatment Drugs Sales by Regions (2012-2017)
Table Global Cancer Treatment Drugs Sales Market Share by Regions (2012-2017)
Table Global Cancer Treatment Drugs Revenue by Regions (2012-2017)
Figure Global Cancer Treatment Drugs Revenue Market Share by Regions in 2012
Figure Global Cancer Treatment Drugs Revenue Market Share by Regions in 2016
Figure North America Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Europe Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Asia-Pacific Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure South America Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Middle East and Africa Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure North America Cancer Treatment Drugs Revenue and Growth (2012-2017)
Table North America Cancer Treatment Drugs Sales by Countries (2012-2017)
Table North America Cancer Treatment Drugs Sales Market Share by Countries (2012-2017)
Figure North America Cancer Treatment Drugs Sales Market Share by Countries in 2012
Figure North America Cancer Treatment Drugs Sales Market Share by Countries in 2016
Table North America Cancer Treatment Drugs Revenue by Countries (2012-2017)
Table North America Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017)
Figure North America Cancer Treatment Drugs Revenue Market Share by Countries in 2012
Figure North America Cancer Treatment Drugs Revenue Market Share by Countries in 2016
Figure USA Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Canada Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Mexico Cancer Treatment Drugs Sales and Growth (2012-2017)
Table North America Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure North America Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure North America Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table North America Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure North America Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure North America Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table North America Cancer Treatment Drugs Sales by Type (2012-2017)
Table North America Cancer Treatment Drugs Sales Share by Type (2012-2017)
Table North America Cancer Treatment Drugs Sales by Application (2012-2017)
Table North America Cancer Treatment Drugs Sales Share by Application (2012-2017)
Figure Europe Cancer Treatment Drugs Revenue and Growth (2012-2017)
Table Europe Cancer Treatment Drugs Sales by Countries (2012-2017)
Table Europe Cancer Treatment Drugs Sales Market Share by Countries (2012-2017)
Table Europe Cancer Treatment Drugs Revenue by Countries (2012-2017)
Table Europe Cancer Treatment Drugs Revenue Market Share by Countries in 2012
Table Europe Cancer Treatment Drugs Revenue Market Share by Countries in 2016
Figure Germany Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure UK Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure France Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Russia Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Italy Cancer Treatment Drugs Sales and Growth (2012-2017)
Table Europe Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Europe Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Europe Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Europe Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Europe Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Europe Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table Europe Cancer Treatment Drugs Sales by Type (2012-2017)
Table Europe Cancer Treatment Drugs Sales Share by Type (2012-2017)
Table Europe Cancer Treatment Drugs Sales by Application (2012-2017)
Table Europe Cancer Treatment Drugs Sales Share by Application (2012-2017)
Figure Asia-Pacific Cancer Treatment Drugs Revenue and Growth (2012-2017)
Table Asia-Pacific Cancer Treatment Drugs Sales by Countries (2012-2017)
Table Asia-Pacific Cancer Treatment Drugs Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Cancer Treatment Drugs Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Cancer Treatment Drugs Revenue by Countries (2012-2017)
Table Asia-Pacific Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017)
Figure China Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Japan Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Korea Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure India Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Southeast Asia Cancer Treatment Drugs Sales and Growth (2012-2017)
Table Asia-Pacific Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Cancer Treatment Drugs Sales by Type (2012-2017)
Table Asia-Pacific Cancer Treatment Drugs Sales Share by Type (2012-2017)
Table Asia-Pacific Cancer Treatment Drugs Sales by Application (2012-2017)
Table Asia-Pacific Cancer Treatment Drugs Sales Share by Application (2012-2017)
Figure South America Cancer Treatment Drugs Revenue and Growth (2012-2017)
Table South America Cancer Treatment Drugs Sales by Countries (2012-2017)
Table South America Cancer Treatment Drugs Sales Market Share by Countries (2012-2017)
Figure South America Cancer Treatment Drugs Sales Market Share by Countries in 2016
Table South America Cancer Treatment Drugs Revenue by Countries (2012-2017)
Table South America Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017)
Figure South America Cancer Treatment Drugs Revenue Market Share by Countries in 2016
Figure South America Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Brazil Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Argentina Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Columbia Cancer Treatment Drugs Sales and Growth (2012-2017)
Table South America Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure South America Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure South America Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table South America Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure South America Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure South America Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table South America Cancer Treatment Drugs Sales by Type (2012-2017)
Table South America Cancer Treatment Drugs Sales Share by Type (2012-2017)
Table South America Cancer Treatment Drugs Sales by Application (2012-2017)
Table South America Cancer Treatment Drugs Sales Share by Application (2012-2017)
Figure Middle East and Africa Cancer Treatment Drugs Revenue and Growth (2012-2017)
Table Middle East and Africa Cancer Treatment Drugs Sales by Countries (2012-2017)
Table Middle East and Africa Cancer Treatment Drugs Sales Market Share by Countries (2012-2017)
Figure Middle East and Africa Cancer Treatment Drugs Sales Market Share by Countries in 2016
Table Middle East and Africa Cancer Treatment Drugs Revenue by Countries (2012-2017)
Table Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Countries in 2012
Figure Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure UAE Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Egypt Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure Nigeria Cancer Treatment Drugs Sales and Growth (2012-2017)
Figure South Africa Cancer Treatment Drugs Sales and Growth (2012-2017)
Table Middle East and Africa Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Cancer Treatment Drugs Sales by Type (2012-2017)
Table Middle East and Africa Cancer Treatment Drugs Sales Share by Type (2012-2017)
Table Middle East and Africa Cancer Treatment Drugs Sales by Application (2012-2017)
Table Middle East and Africa Cancer Treatment Drugs Sales Share by Application (2012-2017)
Table Global Cancer Treatment Drugs Sales by Type (2012-2017)
Table Global Cancer Treatment Drugs Sales Share by Type (2012-2017)
Table Global Cancer Treatment Drugs Revenue by Type (2012-2017)
Table Global Cancer Treatment Drugs Revenue Share by Type (2012-2017)
Figure Global Chemotherapy Sales Growth (2012-2017)
Figure Global Chemotherapy Price (2012-2017)
Figure Global Targeted Therapy Sales Growth (2012-2017)
Figure Global Targeted Therapy Price (2012-2017)
Figure Global Immunotherapy (Biologic Therapy) Sales Growth (2012-2017)
Figure Global Immunotherapy (Biologic Therapy) Price (2012-2017)
Figure Global Hormonal Therapy Sales Growth (2012-2017)
Figure Global Hormonal Therapy Price (2012-2017)
Figure Global Others Sales Growth (2012-2017)
Figure Global Others Price (2012-2017)
Table Global Cancer Treatment Drugs Sales by Application (2012-2017)
Table Global Cancer Treatment Drugs Sales Share by Application (2012-2017)
Figure Global Blood Cancer Sales Growth (2012-2017)
Figure Global Breast Cancer Sales Growth (2012-2017)
Figure Global Gastrointestinal Cancer Sales Growth (2012-2017)
Figure Global Prostate Cancer Sales Growth (2012-2017)
Figure Global Respiratory/Lung Cancer Sales Growth (2012-2017)
Figure Global Other Cancers Sales Growth (2012-2017)
Figure Global Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017 -2022)
Table Global Cancer Treatment Drugs Sales Forecast by Regions (2017-2022)
Table Global Cancer Treatment Drugs Market Share Forecast by Regions (2017-2022)
Figure North America Sales Cancer Treatment Drugs Market Forecast (2017-2022)
Figure Europe Sales Cancer Treatment Drugs Market Forecast (2017-2022)
Figure Asia-Pacific Sales Cancer Treatment Drugs Market Forecast (2017-2022)
Figure South America Sales Cancer Treatment Drugs Market Forecast (2017-2022)
Figure Middle East and Africa Sales Cancer Treatment Drugs Market Forecast (2017-2022)
Table Global Cancer Treatment Drugs Sales Forecast by Type (2017-2022)
Table Global Cancer Treatment Drugs Market Share Forecast by Type (2017-2022)
Table Global Cancer Treatment Drugs Sales Forecast by Application (2017-2022)
Table Global Cancer Treatment Drugs Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/Dealers List